Does serial administration of gadolinium‐based contrast agents affect patient neurological and neuropsychological status? Fourteen‐year follow‐up of patients receiving more than fifty contrast administrations

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis

(2019) Sirio Cocozza et al.   NEURORADIOLOGY

The Cognitive Role of the Globus Pallidus interna; Insights from Disease States

(2017) M. J. Gillies et al.   EXPERIMENTAL BRAIN RESEARCH

Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism

(2016) Blayne Welk et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy

(2015) Tomonori Kanda et al.   RADIOLOGY

Glioblastoma and Other Malignant Gliomas

(2013) Antonio Omuro   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields

(2012) Aaron Rulseh et al.   World Journal of Surgical Oncology

Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE

(2011) Christine A. M. Payan et al.   PLoS One